Scholar Rock Holding Corp (SRRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRK | AMGN | GILD | CELG | VRTX |
| Company | Scholar Rock Holding Corp | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.60 | 273.45 | 67.47 | 108.01 | 402.44 |
| High | 13.82 | 274.35 | 67.90 | 108.59 | 403.88 |
| Low | 13.60 | 271.46 | 66.69 | 107.27 | 397.05 |
| Last | 13.94 | 269.36 | 66.13 | 108.24 | 395.80 |
| Change | -0.15 | -3.65 | -0.95 | +0.11 | -4.96 |
| % Change | -1.06% | -1.34% | -1.42% | +0.10% | -1.24% |
| Volume | 32,959 | 131,451 | 837,070 | 191,230,496 | 68,760 |
| 20-Day Average Volume | 627,758 | 2,061,511 | 6,140,274 | 16,188,930 | 926,363 |
| Previous Close | 14.09 | 273.01 | 67.08 | 108.13 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.53 | 270.82 | 68.76 | 108.17 | 402.40 |
| 20-Day Raw Stochastic | 12.11% | 39.41% | 11.42% | 63.25% | 27.92% |
| 20-Day Relative Strength | 44.73% | 46.88% | 32.30% | 64.69% | 43.92% |
| Weighted Alpha | +51.39 | +10.40 | -21.22 | +46.30 | +15.59 |
| Today's Opinion | 24% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 8% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 48% Buy | 24% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.86% since 04/18/24 | +3.39% since 04/18/24 | +0.98% since 04/18/24 | -1.97% since 11/13/19 | +1.53% since 04/18/24 |
| Low | 13.18 on 04/19/24 | 260.68 on 04/19/24 | 66.16 on 04/19/24 | 107.27 on 11/20/19 | 391.25 on 04/19/24 |
| High | 15.13 on 04/23/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -14.49% since 03/25/24 | -3.26% since 03/25/24 | -7.95% since 03/25/24 | +5.14% since 10/18/19 | -3.97% since 03/25/24 |
| Low | 13.11 on 04/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 17.90 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -8.18% since 01/25/24 | -12.44% since 01/25/24 | -16.73% since 01/25/24 | +13.63% since 08/20/19 | -7.08% since 01/25/24 |
| Low | 12.81 on 03/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 17.90 on 03/28/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +51.77% since 10/25/23 | -0.18% since 10/25/23 | -14.77% since 10/25/23 | +14.14% since 05/20/19 | +10.05% since 10/25/23 |
| Low | 9.00 on 10/26/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 21.17 on 12/28/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,097,132 | 146,436,016 | 83,519,768 | 77,035,920 | 103,580,040 |
| Shares Outstanding, K | 77,866 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -165,790,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -46,130,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.90 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 03/19/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 30.13 |